Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules

This publication has 57 references indexed in Scilit:

• Administration of subtumor regression dosage of TNF-α to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule
  Gene Therapy, 2001
• Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene
  Gene Therapy, 2001
• Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers
  Journal of Biomedical Science, 2000
• HLA class I expression on human cancer cells
  Human Immunology, 2000
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
  JNCI Journal of the National Cancer Institute, 1995
• In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.
  The Journal of Experimental Medicine, 1994
• Evaluation of multiple biologie parameters in cervical carcinoma: high macrophage infiltration in HPV-associated tumors
  International Journal of Gynecologic Cancer, 1993
• An active T-cell-independent mechanism enhances MHC class I transcription and expression on a mouse T-cell lymphoma in vivo
  Cellular Immunology, 1987
• Interferon gamma regulates HLA-D expression on solid tumors in vivo
  European Journal of Cancer and Clinical Oncology, 1986
• Behavior of Mild Cervical Dysplasia During Long-Term Follow-up
  Obstetrics & Gynecology, 1986